Navigation Links
Eqalix Enters Sponsored Research Agreement with Temple University

Reston, VA (PRWEB) December 11, 2012

Under the agreement, Eqalix and Temple Bioengineering Chair and Professor Peter I. Lelkes will jointly advance the development of its three breakthrough technologies for regenerative medicine – protein-based skin substitute, regenerative blood vessels and nerve endings and regeneration of damaged and traumatized organs.

“This arrangement with Temple University works well with our strategy as an emerging company to maintain low overhead costs while accessing leading scientific expertise for the development of our product candidates,” said Eqalix Chairman and CEO Joseph P. Connell. “At the same time, we are building another example of a collaborative effort between the private sector and academia to further the development of novel approaches to treat diseases requiring improved therapies that will address the unmet needs of patients.”

Eqalix is an emerging regenerative medicine development company with a goal of enhancing the quality of life of consumers and patients by providing novel nano-materials for the repair and regeneration of diseased, traumatized and aging tissues. Its innovative technologies are intended to revolutionize the unmet needs in multiple commercial and therapeutic applications in the Regenerative Medicine space.

“We are excited and enthusiastic about entering into a Sponsored Research Agreement with a visionary start-up company such as Eqalix that will entail groundbreaking research in regenerative engineering, as well as the development of innovative and affordable products for wound care and cosmetic applications alike,” said Lelkes, who also serves as director of the Institute for Regenerative Medicine and Engineering in Temple’s School of Medicine.

Eqalix has received exclusive commercial licensing from other Philadelphia institutions for several groundbreaking technologies being developed in the fields of aesthetic dermatology, the consumer market for beauty and skin care, acute and chronic wounds requiring skin replacement, vascular replacements and the repair of traumatic damage to peripheral nerves.

Eqalix plans to leverage these technologies to develop and commercialize: a) plant protein-based nano-fiber scaffolds for use in aesthetic dermatology and wound healing markets; b) small-diameter hybrid vessels that reduce graft thrombogenicity and promote the creation of a functional endothelium after implantation; and c) three-dimensional tissue scaffolds with tunable properties for tissue and organ replacement and repair.

The technologies move the bar higher and intend to replicate the function of damaged, diseased or aging tissues by providing “implants” or scaffolds that are non-immunogenic, bio-compatible, and intended to restore the features and function of the damaged tissue by using the body’s own repair mechanisms. Eqalix is attempting to create skin without scarring and contraction, blood vessels without clotting, repair of injured nerves and organ beyond current capabilities.

“These lofty goals, although seemingly futuristic, are in the immediate realm of scientific possibilities today --- and at Eqalix,” said Connell.

Temple’s new bioengineering department was established in January 2012. Housed in the College of Engineering, Temple’s fastest growing college, the department seeks to provide a well-rounded, in-depth education and a world-class research experience at the interface of engineering, the life sciences and medicine, with the goal of promoting scientific discovery, as well as the development of new technologies that will benefit humanity.

Eqalix, Inc. is a privately held Virginia based C-Corporation located in Reston, VA.
Contact: Joseph P. Connell, 910-233-0806; jconnell (at) eqalix (dot) com

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Pittsburgh Based ParentPlus Enters Collaboration with Vitrolife
2. Two Top Biological Imaging Centers Offer Powerful Free Online Tool to Researchers, Educators, and Public
3. Intellect Neurosciences Enters Collaboration Agreement with Leading Alzheimers Research Group at University of California Irvine to Test First in Class Dual Target Vaccine
4. Novocure™ Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy
5. BioRestorative Therapies Enters Into Brown Fat Research Agreement With University of Utah
6. Top 10 “Best Children’s Hospitals” Include 3 Pediatric Centers Offering SynCardia Total Artificial Heart
7. Centers for Medicare & Medicaid Services Win 2012 National Cybersecurity Innovation Award
8. Nu Skin Enterprises Enters Into Agreement To Acquire NOX Technologies
9. Cell Therapeutics Reports on Cooperative Group Sponsored Trial of Brostallicin in Patients with Metastatic Triple-Negative Breast Cancer
10. Wolters Kluwer Research Now Available via Bloomberg Tradebook
11. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
Post Your Comments:
(Date:11/24/2015)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be ... York on Wednesday, December 2 at 9:30 a.m. ET/6:30 ... CEO, will provide a corporate overview. th Annual ... 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola , ... corporate overview. --> th Annual Oppenheimer Healthcare Conference ...
(Date:11/24/2015)... RALEIGH, N.C. , Nov. 24, 2015  Clintrax Global, Inc., ... Raleigh, North Carolina , today announced that the company has ... earnings represented a 391% quarter on quarter growth posted for Q3 ... Kingdom and Mexico , with the ... place in December 2015. --> United Kingdom ...
(Date:11/24/2015)... --> --> ... by Transparency Market Research, the global non-invasive prenatal testing ... 17.5% during the period between 2014 and 2022. The ... Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 ... to reach a valuation of US$2.38 bn by 2022. ...
(Date:11/24/2015)... ... November 24, 2015 , ... InSphero AG, the leading ... culture models, has promoted Melanie Aregger to serve as Chief Operating Officer. ... on the management team and was promoted to Head of InSphero Diagnostics ...
Breaking Biology Technology:
(Date:11/4/2015)... , November 4, 2015 ... market report published by Transparency Market Research "Home Security Solutions ... and Forecast 2015 - 2022", the global home security solutions ... bn by 2022. The market is estimated to expand ... from 2015 to 2022. Rising security needs among customers ...
(Date:10/29/2015)... 2015   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that it has ... as one of only three finalists for a ... and Growing" category. The Tekne Awards honor Minnesota ... technology innovation and leadership. iMedNet™ eClinical ...
(Date:10/29/2015)... Va. , Oct. 29, 2015 Daon, ... today that it has released a new version of ... customers in North America have ... IdentityX v4.0 also includes a FIDO UAF certified ... are already preparing to activate FIDO features. These customers ...
Breaking Biology News(10 mins):